Vital Care Express

stethoscopeGLP-1 & Metabolic Medicine

Evidence-based coverage of GLP-1 drugs like Ozempic and Wegovy, cholesterol treatments, diabetes and weight-loss medicine, with the safety questions patients actually ask.

Microplastics found in majority of acute heart-attack patients' blood

Study links microplastics to acute heart attacks in 84% of patients

GLP-1 medications linked to 17 % reduction in Danish workers' long-term sick leave

Study finds GLP-1 drugs cut long-term sick leave by 17 % in Denmark

Novo Nordisk files lawsuit accusing Eli Lilly of deceptive GLP-1 advertising

Novo Nordisk sues Eli Lilly over allegedly false GLP-1 weight-loss ads

The GLP-1 Nutrition Gap: Why Meal Replacement Shortcuts May Undermine Weight Loss Success

When GLP-1 Users Swap Meals for Shakes, Health Risks Linger

PROTECT-Cog: The $100 Million Global Effort to Combine Lifestyle and Metabolic Therapy for Dementia Prevention

New $100M Trial Pairs Lifestyle Changes with Metabolic Drugs for Dementia

Neurologists Warn Ozempic and Wegovy May Speed ALS Decline

Doctors flag a hidden GLP-1 risk for people with ALS

FDA Approves Lipfendra (enlicitide): First Oral PCSK9 Inhibitor Pill to Lower Cholesterol

FDA approves Lipfendra, the first oral PCSK9 cholesterol pill